DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Poordad F, Lawitz E, Gutierrez JA et al.
C-SWIFT: Grazoprevir/Elbasvir plus Sofosbuvir in cirrhotic and noncirrhotic, treatment-naive patients with hepatitis C virus genotype 1 infection, for durations of 4, 6 OR 8 weeks and genotype 3 infection for durations of 8 or 12 weeks.

Journal of hepatology 2015;
62: S192-S193

Download Bibliographical Data

Search in: